Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China flag China · Delayed Price · Currency is CNY
12.41
+0.11 (0.89%)
Jun 12, 2026, 3:04 PM CST
Market Cap10.10B -8.6%
Revenue (ttm)4.04B -0.4%
Net Income759.89M +7.9%
EPS0.92 +10.8%
Shares Out 813.76M
PE Ratio13.49
Forward PEn/a
Dividend0.35 (2.82%)
Ex-Dividend DateJun 11, 2026
Volume11,302,301
Open12.31
Previous Close12.30
Day's Range12.18 - 12.59
52-Week Range12.09 - 22.62
Beta-0.11
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat... [Read more]

Sector Healthcare
Founded 1990
Employees 3,732
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002020
Full Company Profile

Financial Performance

In 2025, SHE:002020's revenue was 4.07 billion, a decrease of -2.14% compared to the previous year's 4.16 billion. Earnings were 757.98 million, an increase of 6.46%.

Financial Statements